Observational studyBMC pregnancy and childbirth2025
Association of remifentanil analgesia with postpartum depression and birth experience: an observational study.
Observational study in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPain is a risk factor for postpartum depression. This study aimed to determine the relationship between remifentanil analgesia and postpartum depression, as well as the birth experience among Iranian women.
methodsThis observational study was conducted on 200 mothers who underwent vaginal birth at Taleghani Hospital in Tabriz, Iran, in 2023-4. The Edinburgh Postnatal Depression Scale and the Childbirth Experience Questionnaire were used to assess the outcomes. To compare the childbirth experience and postpartum depression between the exposure group (receiving remifentanil) and the non-exposure group, independent t-tests and Mann-Whitney U tests were employed, respectively.
resultsThe mean postpartum depression score in the remifentanil analgesia group was statistically significantly lower than that in the non-analgesia group (p = 0.002). The mean total childbirth experience score in the exposure group was statistically significantly higher than in the non-exposure group (p < 0.001). Additionally, a comparison of the subdomains of childbirth experience between the two groups showed that the mean scores for own capacity (p < 0.001), perceived safety (p < 0.001), and participation (p < 0.001) were statistically significantly higher in the remifentanil group compared to the non-analgesia group. However, there was no statistically significant difference between the two groups regarding the professional support subdomain (p = 0.434).
conclusionThese findings underscore the significance of using remifentanil analgesia as a potential approach for preventing postpartum depression and creating a positive childbirth experience. It is recommended that clinical trials be conducted to obtain more precise results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.